TCBP Historical Financial Ratios
| TCBP Stock | USD 0.60 0.04 6.25% |
TC BioPharm is promptly reporting on over 83 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 91.27, Invested Capital of 0.0, Average Payables of 836.1 K or Stock Based Compensation To Revenue of 0.25 will help investors to properly organize and evaluate TC BioPharm Holdings financial condition quickly.
TCBP |
About TCBP Financial Ratios Analysis
TC BioPharm HoldingsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate TC BioPharm investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on TCBP financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across TC BioPharm history.
TC BioPharm Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing TC BioPharm Holdings stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on TC BioPharm sales, a figure that is much harder to manipulate than other TC BioPharm Holdings multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Capex To Revenue
The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.Most ratios from TC BioPharm's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into TC BioPharm Holdings current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TC BioPharm Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. At this time, TC BioPharm's Shareholders Equity Per Share is relatively stable compared to the past year. As of 11/30/2024, Revenue Per Share is likely to grow to 1,372, while Operating Cash Flow Per Share is likely to drop (358.41).
| 2023 | 2024 (projected) | Graham Number | 611.53 | 580.95 | Receivables Turnover | 28.62 | 25.44 |
TC BioPharm fundamentals Correlations
Click cells to compare fundamentals
TC BioPharm Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Pair Trading with TC BioPharm
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if TC BioPharm position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TC BioPharm will appreciate offsetting losses from the drop in the long position's value.Moving together with TCBP Stock
Moving against TCBP Stock
| 0.83 | BMY | Bristol Myers Squibb Sell-off Trend | PairCorr |
| 0.81 | GILD | Gilead Sciences | PairCorr |
| 0.78 | ESPR | Esperion Therapeutics Buyout Trend | PairCorr |
| 0.71 | VTRS | Viatris | PairCorr |
| 0.69 | EWTX | Edgewise Therapeutics | PairCorr |
The ability to find closely correlated positions to TC BioPharm could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace TC BioPharm when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back TC BioPharm - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling TC BioPharm Holdings to buy it.
The correlation of TC BioPharm is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as TC BioPharm moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if TC BioPharm Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for TC BioPharm can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for TCBP Stock Analysis
When running TC BioPharm's price analysis, check to measure TC BioPharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TC BioPharm is operating at the current time. Most of TC BioPharm's value examination focuses on studying past and present price action to predict the probability of TC BioPharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TC BioPharm's price. Additionally, you may evaluate how the addition of TC BioPharm to your portfolios can decrease your overall portfolio volatility.